Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

NCT03352206 · clinicaltrials.gov ↗

COMPLETED

Status

20092

Enrollment

OTHER

Sponsor class

Conditions

Lymphatic Filariases

Interventions

DRUG: 2 drug dose - DA
DRUG: 3 drug dose - IDA

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]